Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 159632, 5 pages
http://dx.doi.org/10.1155/2014/159632
Research Article

Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

1Hematology Section of the First Department of Propedeutic Internal Medicine, Laikon University Hospital, Agiou Thoma 17, 11527 Athens, Greece
2Hematology Clinic of Athens’ Medical Center, Andersen 1, Psychiko, 11525 Athens, Greece

Received 17 April 2014; Accepted 20 July 2014; Published 6 August 2014

Academic Editor: Kazuyuki Shimizu

Copyright © 2014 Marie-Christine Kyrtsonis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Marie-Christine Kyrtsonis, Katerina Sarris, Efstathios Koulieris, et al., “Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia,” BioMed Research International, vol. 2014, Article ID 159632, 5 pages, 2014. https://doi.org/10.1155/2014/159632.